Iowa State Bank Gilead Sciences, Inc. Transaction History

Iowa State Bank

$481 Million
Q3 2024

A detailed history of Iowa State Bank transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Iowa State Bank holds 25,733 shares of GILD stock, worth $2.35 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

25,733

Previous 26,225 1.88%

Holding current value

$2.35 Million

Previous $1.8 Million 19.84%

% of portfolio

0.45%

Previous 0.4%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$66.59 - $83.99 $32,762 - $41,323	-492 Reduced 1.88%	25,733 $2.16 Million
Q2 2024 Jul 23, 2024	SELL	$63.15 - $72.88 $663,201 - $765,385	-10,502 Reduced 28.59%	26,225 $1.8 Million
Q1 2024 Apr 23, 2024	SELL	$71.58 - $87.29 $257,043 - $313,458	-3,591 Reduced 8.91%	36,727 $2.69 Million
Q4 2023 Jan 23, 2024	BUY	$73.27 - $83.09 $30,919 - $35,063	422 Added 1.06%	40,318 $3.27 Million
Q3 2023 Oct 24, 2023	BUY	$73.94 - $80.67 $41,850 - $45,659	566 Added 1.44%	39,896 $2.99 Million
Q2 2023 Aug 04, 2023	SELL	$76.01 - $86.7 $48,874 - $55,748	-643 Reduced 1.61%	39,330 $3.03 Million
Q1 2023 Apr 25, 2023	SELL	$77.31 - $88.08 $224,121 - $255,343	-2,899 Reduced 6.76%	39,973 $3.32 Million
Q4 2022 Jan 06, 2023	SELL	$62.32 - $89.47 $103,575 - $148,699	-1,662 Reduced 3.73%	42,872 $3.68 Million
Q3 2022 Oct 14, 2022	BUY	$59.54 - $68.01 $139,442 - $159,279	2,342 Added 5.55%	44,534 $2.75 Million
Q2 2022 Aug 05, 2022	SELL	$57.72 - $65.01 $17,662 - $19,893	-306 Reduced 0.72%	42,192 $2.61 Million
Q1 2022 Apr 27, 2022	BUY	$57.92 - $72.58 $201,967 - $253,086	3,487 Added 8.94%	42,498 $2.53 Million
Q4 2021 Feb 02, 2022	SELL	$64.88 - $73.64 $1,751 - $1,988	-27 Reduced 0.07%	39,011 $2.83 Million
Q3 2021 Oct 12, 2021	BUY	$67.69 - $73.03 $60,853 - $65,653	899 Added 2.36%	39,038 $2.73 Million
Q2 2021 Aug 03, 2021	BUY	$63.47 - $69.35 $7,299 - $7,975	115 Added 0.3%	38,139 $2.63 Million
Q1 2021 Apr 15, 2021	BUY	$60.0 - $68.46 $271,920 - $310,260	4,532 Added 13.53%	38,024 $2.46 Million
Q4 2020 Feb 04, 2021	BUY	$56.65 - $64.55 $385,276 - $439,004	6,801 Added 25.48%	33,492 $1.95 Million
Q3 2020 Oct 19, 2020	BUY	$62.1 - $78.08 $271,687 - $341,600	4,375 Added 19.6%	26,691 $1.69 Million
Q2 2020 Jul 16, 2020	BUY	$72.34 - $84.0 $530,613 - $616,140	7,335 Added 48.96%	22,316 $1.72 Million
Q1 2020 Apr 29, 2020	BUY	$62.63 - $80.22 $938,260 - $1.2 Million	14,981 New	14,981 $1.12 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Iowa State Bank, based on Form 13F filings with the SEC.

News

Stay updated on Iowa State Bank with notifications on news.

Account